Cannabinoid: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (Started Medical uses) |
imported>Robert Badgett |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[pharmacology]], '''cannabinoids''' are "compounds having the cannabinoid structure. They were originally extracted from [[Cannabis sativa]] L. The most pharmacologically active constituents are [[tetrahydrocannabinol]]; [[cannabinol]]; and [[cannabidiol]]."<ref>{{MeSH}}</ref> | In [[pharmacology]], '''cannabinoids''' are "compounds having the cannabinoid structure. They were originally extracted from [[Cannabis sativa]] L. The most pharmacologically active constituents are [[tetrahydrocannabinol]]; [[cannabinol]]; and [[cannabidiol]]."<ref>{{MeSH}}</ref> | ||
| Line 7: | Line 8: | ||
Cannabinoids do ''not'' seem to help dementia.<ref name="pmid19370677">{{cite journal| author=Krishnan S, Cairns R, Howard R| title=Cannabinoids for the treatment of dementia. | journal=Cochrane Database Syst Rev | year= 2009 | volume= | issue= 2 | pages= CD007204 | pmid=19370677 | doi=10.1002/14651858.CD007204.pub2 | pmc= | url= }} </ref> | Cannabinoids do ''not'' seem to help dementia.<ref name="pmid19370677">{{cite journal| author=Krishnan S, Cairns R, Howard R| title=Cannabinoids for the treatment of dementia. | journal=Cochrane Database Syst Rev | year= 2009 | volume= | issue= 2 | pages= CD007204 | pmid=19370677 | doi=10.1002/14651858.CD007204.pub2 | pmc= | url= }} </ref> | ||
Dronabinol, in a single study, may be worse than placebo for neuropathic pain associated with spinal cord injury.<ref name="pmid23874121">{{cite journal| author=Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Desai P, Jalundhwala YJ et al.| title=Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury. | journal=J Pain Res | year= 2013 | volume= 6 | issue= | pages= 539-47 | pmid=23874121 | doi=10.2147/JPR.S45966 | pmc=PMC3712802 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23874121 }} </ref> | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Latest revision as of 04:55, 25 July 2013
In pharmacology, cannabinoids are "compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are tetrahydrocannabinol; cannabinol; and cannabidiol."[1]
Synthetic cannaboids, known as K2, Spice, Demon or Genie are also used for narcotic actions.[2][3]
Medical uses
Cannabinoids may reduce vomiting from chemotherapy.[4]
Cannabinoids do not seem to help dementia.[5]
Dronabinol, in a single study, may be worse than placebo for neuropathic pain associated with spinal cord injury.[6]
References
- ↑ Anonymous (2024), Cannabinoid (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Gay M (July 10, 2010). Synthetic Marijuana Spurs State Bans (English). New York Times. Retrieved on 2010-07-11.
- ↑ Anonymous. Spice Cannabinoid - JWH-018 (English). United States Department of Justice Drug Enforcement Administration. Retrieved on 2010-07-11.
- ↑ Phillips RS, Gopaul S, Gibson F, Houghton E, Craig JV, Light K et al. (2010). "Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.". Cochrane Database Syst Rev (9): CD007786. DOI:10.1002/14651858.CD007786.pub2. PMID 20824866. Research Blogging.
- ↑ Krishnan S, Cairns R, Howard R (2009). "Cannabinoids for the treatment of dementia.". Cochrane Database Syst Rev (2): CD007204. DOI:10.1002/14651858.CD007204.pub2. PMID 19370677. Research Blogging.
- ↑ Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Desai P, Jalundhwala YJ et al. (2013). "Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury.". J Pain Res 6: 539-47. DOI:10.2147/JPR.S45966. PMID 23874121. PMC PMC3712802. Research Blogging.